3rd Quarter - Report
LEWIS-BURKE ASSOCIATES, LLC for DANAHER CORPORATION
Client
Income
$36,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues pertaining to the regulation of cell and gene therapy products. Issues pertaining to the biomedical research enterprise.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL ANTHONY PETERSON | Legislative Director, Sen. Leg. Assistant, Leg. Assistant, Leg. Correspondent/Digital Media Specialist, Staff Assistant, Intern, Congressman Peter J. Visclosky |
| ANJALI HELENA TADAVARTHY | Paid Intern - Washington DC Office of Senator Tina Smith |
Budget/Appropriations BUD
H.R. 8646, FY 2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, Issues related to cell and gene therapy products at FDA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL ANTHONY PETERSON | Legislative Director, Sen. Leg. Assistant, Leg. Assistant, Leg. Correspondent/Digital Media Specialist, Staff Assistant, Intern, Congressman Peter J. Visclosky |
| ANJALI HELENA TADAVARTHY | Paid Intern - Washington DC Office of Senator Tina Smith |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.